Mutual of America Capital Management LLC Purchases Shares of 16,499 Revvity, Inc. (NYSE:RVTY)

Mutual of America Capital Management LLC acquired a new position in Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,499 shares of the company’s stock, valued at approximately $1,804,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Gladius Capital Management LP raised its stake in Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock valued at $26,000 after purchasing an additional 106 shares during the period. CENTRAL TRUST Co purchased a new stake in Revvity during the 4th quarter valued at approximately $27,000. JTC Employer Solutions Trustee Ltd bought a new stake in shares of Revvity during the fourth quarter valued at approximately $33,000. Headinvest LLC purchased a new position in Revvity during the third quarter valued at $57,000. Finally, DB Wealth Management Group LLC bought a new stake in Revvity in the 4th quarter valued at $79,000. 86.65% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have commented on RVTY shares. KeyCorp increased their price objective on shares of Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Evercore ISI raised Revvity from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $88.00 to $125.00 in a report on Thursday, January 4th. Raymond James raised their target price on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Stifel Nicolaus upped their price target on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research note on Friday, February 2nd. Finally, Barclays lifted their price objective on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $118.91.

Revvity Stock Performance

RVTY stock opened at $100.86 on Monday. The firm has a market cap of $12.46 billion, a price-to-earnings ratio of 18.34, a PEG ratio of 2.63 and a beta of 1.09. Revvity, Inc. has a twelve month low of $79.50 and a twelve month high of $135.67. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40. The business’s fifty day simple moving average is $104.78 and its two-hundred day simple moving average is $101.56.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. Analysts predict that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be issued a $0.07 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity’s payout ratio is 5.09%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.